Recent Updates — IMCC
IM Cannabis Corp. closed the sale of its European-focused operations via IMC Holdings to Slil.com Holding Ltd., a company controlled by CEO Oren Shuster, on September 29, 2026. The transaction involved an advance payment of C$3 million and the transfer of liabilities capped at C$9.4 million, which are retained within IMC Holdings rather than assumed by the buyer. Management expects this restructuring to improve shareholders' equity by approximately C$3 million and streamline the corporate structure. Following the sale, the company intends to focus resources on its retained Israeli medical cannabis operations. IM Cannabis Corp. operates a medical cannabis platform serving patients in Israel through importation, distribution, retail pharmacies, and online delivery services.
On September 27, 2026, Einat Zakariya resigned from the board of directors and all committees of IM Cannabis Corp., effective immediately, citing personal reasons with no disagreements regarding operations or policies. The resignation was accompanied by a corporate update press release issued on September 28, 2026. This filing is not material as it involves a routine director departure unrelated to operational disputes. IM Cannabis Corp. operates in the medical cannabis industry, serving patients in Israel and Germany through importation, distribution, retail pharmacies, and online platforms.
IM Cannabis Corp. closed a registered direct offering of common shares, selling 655,000 units to accredited investors at $2.00 per share for aggregate gross proceeds of US$1.31 million. The company intends to use the net proceeds for working capital and general corporate purposes. A related party transaction occurred wherein Invest-Pro SHUKAI HON LTD., associated with director Eli Zamir, subscribed for 164,585 shares at $2.00 per share for US$329,170. The company relied on exemptions from formal valuation and minority shareholder approval requirements under Multilateral Instrument 61-101 due to serious financial difficulty and liquidity constraints. IM Cannabis Corp. operates in the medical cannabis industry, serving patients through operations in Israel and Germany.
On September 23, 2026, IM Cannabis Corp. entered into securities purchase agreements to issue and sell 655,000 common shares at $2.00 per share in a registered direct offering. The transaction generated approximately $1,310,000 in gross proceeds before expenses, with closing expected on September 24, 2026. Proceeds are designated for working capital and general corporate purposes, including evaluating potential business opportunities. The company operates in the medical cannabis industry.
IM Cannabis Corp. regained compliance with Nasdaq's minimum bid price requirement on September 23, 2026, after its ordinary shares closed at $1.00 or greater for 18 consecutive business days from August 27 to September 22, 2026. The company received written notice from Nasdaq confirming the deficiency matter is now closed. IM Cannabis Corp. operates a medical cannabis platform serving patients in Israel and Germany.
IM Cannabis Corp. entered a non-binding Letter of Intent to acquire a 51% controlling stake in Space Defense Innovations LLC (SDI), a Polish entity distributing BlueBird Aero Systems’ tactical unmanned aerial systems in Europe. The transaction involves consideration via IMCC common shares and/or pre-funded warrants, capped to prevent any SDI shareholder from exceeding 19.99% ownership of IMCC, plus a 24-month seller loan with 9% interest and warrant coverage. IMCC will also receive a five-year call option for the remaining shares, board control rights, and an on-demand line of credit up to EUR 2.3 million convertible into SDI equity at closing, subject to a minimum valuation of US$5 million. Definitive agreements are targeted within 60 days, pending due diligence and regulatory approvals. IM Cannabis Corp. operates in the medical cannabis industry, importing and distributing cannabis products to patients in Israel and Germany.